NEW YORK (GenomeWeb) – Natera has drawn $10 million from a credit facility with UBS Bank that provides a $50 million revolving line of credit, the company said yesterday in a regulatory filing.

The $10 million draw down will provide working capital for Natera to use on a temporary basis for "certain obligations." The draw down decreased the total principal amount outstanding under the credit line to $42 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.